Skip to main content
Back
OMER logo

Omeros Corporation

Data quality: 100%
OMER
NASDAQ Healthcare Biotechnology
$10.66
▼ $0.34 (-3.09%)
Mkt Cap: 755.80M
Day Range
$10.59 $11.44
52-Week Range
$2.95 $17.65
Volume
1,185,013
50D / 200D Avg
$11.75 / $7.57
Prev Close
$11.00

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -4.8 0.4
P/B 2.9
ROE % 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.2

Key Takeaways

Negative free cash flow of -148.97M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-520.03%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.69
Interest Coverage-6.86

Valuation

P/E Ratio
-4.82
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -156.82M
ROE N/A ROA -56.60%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -148.97M
ROIC -520.03% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.69
Interest Coverage -6.86 Dividend Yield 0.00%
Valuation
P/E Ratio -4.82 P/B Ratio N/A
P/S Ratio N/A PEG Ratio -0.08
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 755.80M Enterprise Value 959.42M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -156.82M -117.81M 47.42M -111.41M -138.06M
EPS (Diluted) -2.70 -1.88 0.46 3.12 -2.41
Gross Profit 0.0 0.0 0.0 -1.39M -1.62M
Operating Income -169.26M -164.53M -163.39M -173.62M -156.92M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 277.08M 378.27M 590.97M 419.27M 181.04M
Total Liabilities 459.69M 403.25M 505.29M 395.49M 301.79M
Shareholders' Equity -182.61M -24.98M 85.68M 23.78M -120.75M
Total Debt 207.02M 361.58M 342.02M 347.84M 268.84M
Cash & Equivalents 3.40M 7.11M 11.01M 100.81M 10.50M
Current Assets 134.12M 217.90M 443.24M 247.96M 151.29M
Current Liabilities 79.53M 53.32M 136.38M 51.79M 36.74M